loadpatents
name:-0.019505977630615
name:-0.03168797492981
name:-0.00042986869812012
N.V. Innogenetics S.A. Patent Filings

N.V. Innogenetics S.A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for N.V. Innogenetics S.A..The latest application filed is for "isolsted monoclonal - associated protein tau and kit".

Company Profile
0.31.13
  • N.V. Innogenetics S.A. - Ghent BE
  • N.V. Innogenetics S.A. - Gent BE
  • N.V. INNOGENETICS S.A. -
  • N. V. Innogenetics S.A. - BE BE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Isolated microtubule-associated protein tau peptides and kit
Grant 8,163,873 - Mercken , et al. April 24, 2
2012-04-24
Isolsted Monoclonal - Associated Protein Tau and Kit
App 20110143443 - Mercken; Marc ;   et al.
2011-06-16
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
Grant 7,855,052 - Maertens , et al. December 21, 2
2010-12-21
Monoclonal Antibodies Directed Against The Microtubule-Associated Protein Tau
App 20090137051 - Mercken; Marc ;   et al.
2009-05-28
Sequences of Hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
App 20070243524 - Maertens; Geert ;   et al.
2007-10-18
32-kDa protein derived from Mycobacterium tuberculosis and related peptides
Grant 7,279,170 - Content , et al. October 9, 2
2007-10-09
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
Grant 7,255,997 - Maertens , et al. August 14, 2
2007-08-14
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
Grant 7,195,765 - Maertens , et al. March 27, 2
2007-03-27
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
Grant 7,122,306 - Maertens , et al. October 17, 2
2006-10-17
32-kDa protein derived from Mycobacterium tuberculosis and related peptides
Grant 7,083,797 - Content , et al. August 1, 2
2006-08-01
Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
App 20060078932 - Maertens; Geert ;   et al.
2006-04-13
Monoclonal antibodies directed against the microtubule-associated protein tau and method of detecting the same
App 20060008853 - Mercken; Marc ;   et al.
2006-01-12
Monoclonal antibodies directed against the microtubule-associated protein tau
Grant 6,900,293 - Mercken , et al. May 31, 2
2005-05-31
Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them
App 20050049398 - De Leys, Robert
2005-03-03
Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
Grant 6,855,318 - Maertens , et al. February 15, 2
2005-02-15
Multi-mer peptides derived from hepatitis C virus envelope proteins for diagnostic use and vaccination purposes
App 20040126754 - Maertens, Geert ;   et al.
2004-07-01
Process For The Determination Of Peptides Corresponding To Immunologically Important Epitopes And Their Use In A Process For Determination Of Antibodies Or Biotinylated Peptides Corresponding To Immunologically Important Epitopes, A Process For Preparing Them And Compositions Containing Them
Grant 6,709,828 - De Leys March 23, 2
2004-03-23
Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms
App 20040053320 - Rossau, Rudi ;   et al.
2004-03-18
HCV core peptides
Grant 6,667,387 - De Leys December 23, 2
2003-12-23
Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms
Grant 6,656,689 - Rossau , et al. December 2, 2
2003-12-02
Process For The Determination Of Peptides Corresponding To Immunologically Important Epitopes And Their Use In A Process For Determination Of Antibodies Or Biotinylated Peptides Corresponding To Immunologically Important Epitopes, A Process For Preparing Them And Compositions Containing Them
Grant 6,649,735 - De Leys November 18, 2
2003-11-18
Mycobacterium polypeptides and nucleic acids encoding them for diagnosis and control of tuberculosis
Grant 6,638,511 - Content , et al. October 28, 2
2003-10-28
Non-viable keratinocyte cell composition or lysate for promoting wound healing
Grant 6,585,969 - Van Bossuyt July 1, 2
2003-07-01
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
App 20030064360 - Maertens, Geert ;   et al.
2003-04-03
Sequences of hepatitis C virus genotypes and their use as therapeutic and diagnostic agents
App 20030008274 - Maertens, Geert ;   et al.
2003-01-09
Polypeptides from mycrobacterium paratuberculosis
Grant 6,387,372 - Cocito , et al. May 14, 2
2002-05-14
Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms
App 20020048762 - Rossau, Rudi ;   et al.
2002-04-25
Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
App 20020001857 - Vandermeeren, Marc ;   et al.
2002-01-03
Monoclonal antibodies directed against the microtubule-associated protein tau
App 20010018191 - Mercken, Marc ;   et al.
2001-08-30
Hybridization probes derived from the spacer region between the 16s and 23s RRNA genes for the detection of non-viral microorganisms
Grant 6,277,577 - Rossau , et al. August 21, 2
2001-08-21
Monoclonal antibodies directed against the microtubule-associated protein tau
Grant 6,238,892 - Mercken , et al. May 29, 2
2001-05-29
Isolated human tau peptide epitope which specifically binds monoclonal antibody AT120.
Grant 6,232,437 - Vandermeeren , et al. May 15, 2
2001-05-15
Pellets obtained from cell cultures of keratinocytes and their use in wound healing
Grant 6,126,935 - Van Bossuyt October 3, 2
2000-10-03
Process for typing of HCV isolates
Grant 6,051,696 - Maertens , et al. April 18, 2
2000-04-18
Isolated human tau peptide
Grant 6,010,913 - Vandermeeren , et al. January 4, 2
2000-01-04
Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms
Grant 5,945,282 - Rossau , et al. August 31, 1
1999-08-31
TNF-alpha muteins and a process for preparing them
Grant 5,891,679 - Lucas , et al. April 6, 1
1999-04-06
Peptide derived from human immunodeficiency virus type 1 (HIV-1), isolate ant70, containing an immunodominant epitope and it's use in immunodiagnostic assays
Grant 5,891,640 - De Leys April 6, 1
1999-04-06
Monoclonal antibodies directed against the microtubule-associated protein tau, hybridomas secreting these antibodies, antigen recognition by these monoclonal antibodies and their applications
Grant 5,861,257 - Vandermeeren , et al. January 19, 1
1999-01-19
Process for typing of HCV isolates
Grant 5,846,704 - Maertens , et al. December 8, 1
1998-12-08
Monoclonal antibodies directed against the microtubule-associated protein tau, and hybridomas secreting these antibodies
Grant 5,843,779 - Vandermeeren , et al. December 1, 1
1998-12-01
Polynucleotide tuberculosis vaccine
Grant 5,736,524 - Content , et al. April 7, 1
1998-04-07
Peptides and proteins, process for their preparation and their use as cholesterol acceptors
Grant 5,733,879 - Rosseneu , et al. March 31, 1
1998-03-31
Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of Neisseria gonorrhoeae
Grant 5,536,638 - Rossau , et al. July 16, 1
1996-07-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed